Atlas Trials

Ambispective Observational Multicenter Study on the Efficacy of the Third Dose of Vaccine Anti COVID-19 in Patients Suffering From Solid Tumors Undergoing Oncological Treatment Active.

Clinical trial NCT06334744 · COMPLETED

Trial details

NCT number
NCT06334744
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Status
COMPLETED
Study type
OBSERVATIONAL
Oncologic Complications
Start date
2021-11-17
Primary completion
2023-01-08
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.